Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
128.4 USD | -0.70% | -1.60% | +17.68% |
02:36pm | US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine | RE |
May. 13 | Merck: phase 3 trial in melanoma halted | CF |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.